Science & Technology
Science and Technology
Science and Technology
Thu, September 8, 2011
Harwood Feffer LLP Announces Investigation of Caliper Life Sciences Inc.
NEW YORK--([ BUSINESS WIRE ])--Harwood Feffer LLP ([ www.hfesq.com ]) is investigating potential claims against the board of directors of Caliper Life Sciences, Inc. (ACalipera or the ACompanya) (NASDAQ: CALP) concerning the proposed acquisition of the Company by PerkinElmer, Inc. (aPerkinElmera) (NYSE: PKI), in a transaction valued at approximately $600 million.
On September 8, 2011, it was announced that Caliper and PerkinElmer had signed a definitive agreement under which Caliper shareholders will receive $10.50 per share for each share they own. Kevin Hrusovsky, CEO of the Company, is expected to join the PerkinElmer senior leadership team following the close of the transaction. Our investigation concerns whether the board of directors undertook a fair process, adequately shopped the Company, and disclosed all material information to shareholders prior to approving the proposed transaction.
If you own shares of Caliper and would like to learn more about these claims or if you wish to discuss this matter and have any questions or information concerning this announcement, please contact Daniella Quitt, Esq. at [ dquitt@hfesq.com ] or Benjamin Sachs-Michaels at [ bsachsmichaels@hfesq.com ]. You may also call them at (877) 935-7400. For more information about class actions, or to sign up online, please visit our website: [ www.hfesq.com ].
Harwood Feffer LLP is a national shareholder litigation firm. Harwood Feffer LLP is devoted to protecting the interests of individual and institutional investors in shareholder actions in state and federal courts nationwide.
Attorney Advertising. © 2011 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP ([ www.hfesq.com ]). Prior results do not guarantee or predict a similar outcome with respect to any future matter.
